Company Alopexx, Inc.
Equities
ALPX
US02052J1016
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gerald B. Pier
FOU | Founder | 72 | 19-03-22 |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 19-03-22 |
Thomas T. Thomas
DFI | Director of Finance/CFO | 66 | 21-07-31 |
Corporate Officer/Principal | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Werth
BRD | Director/Board Member | 85 | - |
Ann MacDougall
BRD | Director/Board Member | 70 | - |
Richard Cohen
BRD | Director/Board Member | 73 | - |
William Chin
BRD | Director/Board Member | 76 | - |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 19-03-22 |
Gail H. Cassell
BRD | Director/Board Member | 77 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,847,178 | 0 | 0 | - |
Company contact information
![address Alopexx, Inc.(ALPX)](https://cdn.zonebourse.com/static/address/145003320.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.44B | |
+37.63% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |